What is Avalo Therapeutics's net margin?

Avalo Therapeutics (AVTX) reported net margin of -7,965.8% in Q4 2024.

How has Avalo Therapeutics's net margin changed year-over-year?

Avalo Therapeutics's net margin decreased by 386.1% year-over-year, from -1,638.6% to -7,965.8%.

What is the long-term trend for Avalo Therapeutics's net margin?

Over 4 years (2020 to 2024), Avalo Therapeutics's net margin has grown at a 70.3% compound annual growth rate (CAGR), from -947.8% to -7,965.8%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Avalo Therapeutics AVTX Net margin

Net margin at other companies

Eli LillyLLY

35%+12.3pp

AbbVieABBV

5.8%-1.5pp

XencorXNCR

-177.1%+16.5pp

AbCellera Biologics Inc.ABCL

-181.7%-77.9pp

AnaptysBio, Inc.ANAB

-49.9%-22.6pp

Absci CorporationABSI

-6,450.8%-13,699pp

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$954.59M+1,800%

Enterprise value$929.6M-1,353%

P/S1,909.2×+1,868×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Calculated from Avalo Therapeutics’s reported figures.

net income/total revenue=-7,965.8%

Based on trailing twelve months.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's net margin?: Avalo Therapeutics (AVTX) reported net margin of -7,965.8% in Q4 2024.
How has Avalo Therapeutics's net margin changed year-over-year?: Avalo Therapeutics's net margin decreased by 386.1% year-over-year, from -1,638.6% to -7,965.8%.
What is the long-term trend for Avalo Therapeutics's net margin?: Over 4 years (2020 to 2024), Avalo Therapeutics's net margin has grown at a 70.3% compound annual growth rate (CAGR), from -947.8% to -7,965.8%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.